Medicus Pharma Ltd

MDCX
$0.42 (+ $0.02 + 4.07%)
Last updated: 2026-07-03 01:11 UTC
MDCX Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorHealthcare
IndustryDrug Manufacturers - General
ISINN/A
Market Price0.42
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend Frequency N/A
P/E RatioN/A
EPS-2.23
Market Cap$38.3M
Book Value-0.04
Price to Book-36.047
Beta-0.96
52w High8.94
52w Low1.49
Next Earnings DateN/A

Medicus Pharma Ltd trades under ticker MDCX on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure.

About the Company
Medicus Pharma Ltd is a precision-guided biotech and life sciences company focused on accelerating the clinical development of novel and potentially disruptive therapeutic assets. Operating as a clinical-stage, multi-strategy holding company, the company identifies, acquires, and advances relatively de-risked clinical-stage assets through clinical development and commercialization. The company leverages its diverse experience and extensive industry network to evaluate therapeutic opportunities across multiple disease areas where unmet patient needs exist for improved safety and efficacy. Medicus Pharma's leadership team brings decades of cumulative experience in advancing novel therapies through clinical evaluation, regulatory approval, and strategic partnership discussions. The company explores opportunities to expand its drug development pipeline through qualified and accretive acquisitions and partnerships, with a commitment to delivering better treatment outcomes and alleviating patient suffering.
Price History